Xingchen Bian

Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjects

Xiaofen Liu, Yuancheng Chen, Haijing Yang et al. · Journal of Infection · 2021 · 50 citations

Intravenous Polymyxin B, Health Sciences, Healthy Chinese Subjects +10

Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model

Xiaofen Liu, Miao Zhao, Yuancheng Chen et al. · International Journal of Antimicrobial Agents · 2016 · 48 citations

Antimicrobial Susceptibility, Health Sciences, Antibiotics +14

Therapeutic Drug Monitoring of Polymyxin B by LC–MS/MS in Plasma and Urine

Xiaofen Liu, Zhenwei Yu, Yu Wang et al. · Bioanalysis · 2020 · 33 citations

Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii

Xingchen Bian, Xiaofen Liu, Meiqing Feng et al. · International Journal of Antimicrobial Agents · 2020 · 25 citations

Antimicrobial Susceptibility, Health Sciences, Antibiotics +10

Epidemiological and genomic characteristics of Acinetobacter baumannii from different infection sites using comparative genomics

Xingchen Bian, Xiaofen Liu, Xuefei Zhang et al. · BMC Genomics · 2021 · 25 citations · Full text